Epicrispr Biotechnologies Revenue

Biotechnology Research • Brisbane, California, United States • 21-50 Employees

Epicrispr Biotechnologies revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$23,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	No funding

Key Contacts at Epicrispr Biotechnologies

Amber Salzman

Ceo

Nalinda Wasala

Associate Director, Therapeutics

Libby Cooper

Associate Director, Program Management

Company overview

Headquarters	7000 Shoreline Ct, Suite 100, South San Francisco, CA 94080, US
Websites	epicrispr.com epic-bio.com
NAICS	541714
Founded	2018
Employees	21-50
Socials

Epicrispr Biotechnologies Email Formats

Epicrispr Biotechnologies uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@epic-bio.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@epic-bio.com	100%

About Epicrispr Biotechnologies

Epicrispr Biotechnologies is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Head

Employees by Department

Epicrispr Biotechnologies has 18 employees across 5 departments.

Departments

Number of employees

Funding Data

Epicrispr Biotechnologies has never raised funding before.

Epicrispr Biotechnologies Tech Stack

Discover the technologies and tools that power Epicrispr Biotechnologies's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Gravity Forms

Form builders

Vimeo

Video players

lit-element

JavaScript libraries

lit-html

JavaScript libraries

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

Yoast SEO Premium

SEO

jQuery

JavaScript libraries

GeneratePress

WordPress themes

HTTP/3

Miscellaneous

Frequently asked questions

Epicrispr Biotechnologies is located in Brisbane, California, US.

Epicrispr Biotechnologies generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Epicrispr Biotechnologies has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Epicrispr Biotechnologies was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Epicrispr Biotechnologies has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Epicrispr Biotechnologies

Amber Salzman

Ceo

Nalinda Wasala

Associate Director, Therapeutics

Libby Cooper

Associate Director, Program Management

4.8

40,000 users